Mortality Rates Across 25-Hydroxyvitamin D (25[OH]D) Levels among Adults with and without Estimated Glomerular Filtration Rate <60 ml/min/1.73 m2: The Third National Health and Nutrition Examination Survey

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Kramer, Holly ^a   Sempos, Chris ^b   Cao, Guichan ^a   Luke, Amy ^a   Shoham, David ^a   Cooper, Richard ^a   Durazo Arvizu, Ramon ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE; VITAMIN D;

ADULT; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATION; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HEART INFARCTION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; POISSON DISTRIBUTION; PREVALENCE; RACE; SYSTOLIC BLOOD PRESSURE; WINTER;

AGED; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; NUTRITION SURVEYS; VITAMIN D;

EID: 84868156526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047458     Document Type: Article

References (41)

1. Holick MF, (2007) Vitamin D deficiency. New England Journal of Medicine 357: 266-281.
2. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Institute of Medicine. (2011) Dietary reference intakes for calcium and vitamin D.: National Academies Press.
3. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism 96: 1911-1930.
4. Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, et al. (2009) Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney International 76: 977-983.
5. Melamed ML, Michos ED, Post W, Astor B, (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Archives of Internal Medicine 168: 1629-1637.
6. Malabanan A, Veronikis IE, Holick MF, (1998) Redefining vitamin D insufficiency. Lancet 351: 805-806.
7. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, et al. (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International 7: 439-443.
8. Aloia JF, Talwar SA, Pollack S, Feuerman M, Yeh JK, (2006) Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. American Journal of Clinical Nutrition 84: 602-609.
9. Adami S, Viapiana O, Gatti D, Idolazzi L, Rossini M, (2008) Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. Bone 42: 267-270.
10. Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, et al. (2008) Hypovitaminosis D in chronic kidney disease. Clinical Journal of the American Society of Nephrology: CJASN 3: 1144-1151.
11. [Anonymous] (1996) National Center for Health Statistics: Survey design of the Third National Health and Nutrition Examination Survey, 1988-1994.
12. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS, (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation 41: 1-12.
13. Selvin E, Manzi J, Stevens LA, Van Lente F, Lacher DA, et al. (2007) Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation 50: 918-926.
14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, et al. (2009) A new equation to estimate glomerular filtration rate. Annals of Internal Medicine 150: 604-612.
15. [Anonymous]. National Center for Health Statistics. NHANES III linked mortality file-public use file. January 3, 2010.
16. [Anonymous] (1991) World Health Organization. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).
17. [Anonymous] (1992) World Health Organization. International Statistical Classification of Diseases and Related Health Problems. Tenth revision. (ICD-10-CM).
18. [Anonymous] (2010) Survey operations manuals, brochures, and consent documents: 1999-curent NHANES. 2010.
19. Harrell FE, Lee KL, Mark DB, (1996) Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine 15: 361-387.
20. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, et al. (2009) Vitamin D levels and patient outcome in chronic kidney disease. Kidney International 75: 88-95.
21. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, et al. (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney International 72: 1004-1013.
22. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511.
23. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, et al. (2012) Vitamin D deficiency and mortality risk in the general population: A meta-analysis of prospective cohort studies. American Journal of Clinical Nutrition 95: 91-100.
24. Michaelsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, et al. (2010) Plasma vitamin D and mortality in older men: A community-based prospective cohort study. American Journal of Clinical Nutrition 92: 841-848.
25. Cawthon PM, Parimi N, Barrett-Connor E, Laughlin GA, Ensrud KE,et al. Osteoporotic Fractures in Men (MrOS) Research Group (2010) Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. Journal of Clinical Endocrinology & Metabolism 95: 4625-4634.
26. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, et al. (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney International 71: 31-38.
27. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, et al. (2005) Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the united states. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation 45: 1026-1033.
28. Norman AW, (2008) A vitamin D nutritional cornucopia: New insights concerning the serum 25-hydroxyvitamin D stats of the US population. Am.J.Clin.Nutr. 88: 1455.
29. Pilz S, Tomaschitz A, Ritz E, Pieber TR, (2009) Medscape (2009) Vitamin D status and arterial hypertension: A systematic review. Nature Reviews Cardiology 6: 621-630.
30. Pilz S, Dobnig H, Fischer JE, Wellnitz B, Seelhorst U, et al. (2008) Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke; a Journal of Cerebral Circulation 39: 2611-2613.
31. Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, et al. (2009) 25-hydroxyvitamin D levels, race, and the progression of kidney disease. Journal of the American Society of Nephrology 20: 2631-2639.
32. Michos ED, (2009) Vitamin D deficiency and the risk of incident type 2 diabetes. Future Cardiology 5: 15-18.
33. Autier P, Gandini S, (2007) Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Archives of Internal Medicine 167: 1730-1737.
34. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, et al. (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries. International Journal of Cancer 108: 104-108.
35. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, et al. (2010) Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort consortium vitamin D pooling project of rarer cancers. American Journal of Epidemiology 172: 81-93.
36. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, et al. (2006) Calcium plus vitamin D supplementation and the risk of fractures. The New England Journal of Medicine 354: 669-683.
37. Miller ER,3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, et al (2005) Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Annals of Internal Medicine 142: 37-46.
38. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, et al. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. The New England Journal of Medicine 334: 1150-1155.
39. Greenberg ER, (2005) Vitamin E supplements: Good in theory, but is the theory good? Annals of Internal Medicine 142: 75-76.
40. Hollis BW, (2008) Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Current Opinion in Endocrinology, Diabetes and Obesity. 15: 489-494.
41. Emmanuele E, (2012) To D or not to D? Social deprivation as a confounder of the association between 25-hydroxyvitamin D and atherosclerosis. Atherosclerosis. 223: 280-1.